Clinical Archives - BioAegis Therapeutics

Steven Opal, M.D. (In Memoriam)

serrao6 — Tue, 21 Jan 2020 15:00:00 +0000

In Memoriam

The post Steven Opal, M.D. (In Memoriam) appeared first on BioAegis Therapeutics.

Wesley H. Self, MD, MPH

serrao6 — Tue, 21 Jan 2020 14:00:00 +0000

Dr. Wesley H. Self, MD, MPH, is the Vice Chair for Research in the Department of Emergency Medicine at Vanderbilt University Medical Center in Nashville, Tennessee, USA. He is an emergency physician and researcher focused on the prevention and acute management of pneumonia, sepsis and influenza infections. He has published over 140 peer-reviewed publications and […]

The post Wesley H. Self, MD, MPH appeared first on BioAegis Therapeutics.

Jean-Louis Vincent, MD

serrao6 — Tue, 21 Jan 2020 13:00:00 +0000

The post Jean-Louis Vincent, MD appeared first on BioAegis Therapeutics.

Richard G. Wunderink, MD

serrao6 — Tue, 21 Jan 2020 12:00:00 +0000

Richard Wunderink, MD, is a professor of medicine in the Pulmonary and Critical Care Division of Northwestern University’s Feinberg School of Medicine and medical director of the MICU, Northwestern Memorial Hospital. His research and education focus includes pulmonary infections, especially ventilator-associated pneumonia and community-acquired pneumonia and sepsis. He served as co-chairman of the most recent […]

The post Richard G. Wunderink, MD appeared first on BioAegis Therapeutics.

Po-Shun Lee, MD

serrao6 — Tue, 21 Jan 2020 11:00:00 +0000

Po-Shun Lee is pulmonary and critical care physician who worked in Dr. Stossel’s lab for 10 years and conducted rhu-pGSN in preclinical animal models. Dr. Lee has presented at the American Thoracic Society International Meeting on the subject of pGSN’s clinical and scientific implications. In 2004, Dr. Lee received an award from the New England […]

The post Po-Shun Lee, MD appeared first on BioAegis Therapeutics.

Mark J. DiNubile, MD, FIDSA

serrao6 — Tue, 21 Jan 2020 10:00:00 +0000

Mark J. DiNubile, MD, FIDSA, has been a founding member of the BioAegis team and key advisor to BioAegis Therapeutics since its inception, providing leadership in clinical strategy, including serving as Chief Medical Officer. He brings to the table the rare combination of clinical and research expertise along with broad pharmaceutical industry experience, coupled with […]

The post Mark J. DiNubile, MD, FIDSA appeared first on BioAegis Therapeutics.